Both organic and inorganic forms of selenium (Se) can be utilized in t
he body, and the biotransformation of selenite into an organic form of
Se in the bloodstream is the first step for the utilization of inorga
nic Se, Selenite injected intravenously into rats was shown to be take
n up rapidly and selectively by red blood cells (RBCs) through the ani
on-exchange carrier, The uptake of selenite by RBCs was inhibited by 4
,4'-diisothiocyano-2,2'-stilbene disulfonate, a specific inhibitor of
the anion-exchange carrier (band 3 protein), The uptake was also inhib
ited by chromate owing to the glutathione deprivation in RBCs, which w
as confirmed by the inhibition by azodicarboxylic acid bis(dimethylami
de). The presence of hydrogencarbonate in the incubation solution slig
htly retarded the uptake of selenite by RBCs, Although Se effluxed int
o the plasma was bound selectively to albumin, plasma proteins (albumi
n) did not accelerate the uptake process, Based on these results, the
rapid and selective uptake of selenite by RBCs was explained by the se
lective and efficient uptake through the anion-exchange carrier, follo
wed by reduction by glutathione.